ADRX EFFECT: SEC filing
ADARx Pharmaceuticals, Inc.
Filed with the SEC on · accession 9999999995-26-003052
ADRX filed a EFFECT (effect) with the SEC on Sep 24, 2026. A report the company filed with the SEC (the US market regulator).
Summary of the filing
ADARx Pharmaceuticals, Inc. filed an EFFECT notice with the SEC, indicating that a previously filed registration statement has become effective.
Key details
✦ Ask GOAX AI about this filing — what it means for ADRX, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for ADRX?
Click hereFrequently asked questions
What did ADRX file with the SEC on Sep 24, 2026?
ADRX filed a EFFECT (SEC filing). ADARx Pharmaceuticals, Inc. filed an EFFECT notice with the SEC, indicating that a previously filed registration statement has become effective.
How do I read a EFFECT?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A EFFECT (effect): A report the company filed with the SEC (the US market regulator).
Other ADRX SEC filings
Get alerts when ADRX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days